Lonza invests in biomanufacturing

Lonza is to expand its biopharmaceutical manufacturing facility in Slough, UK. The company will invest £16m in a 6000m2M/sup> building including a fermentation suite, purification suites, process development laboratories and a GMP warehouse. The company expects the facility, which will allow it to respond to a broader range of customer projects, to be completed by the end of 2012.
The Engineer